Veterinary Pharmaceuticals Market SWOT Analysis by Key Players Zoetis, Merial, Virbac, Ceva
iCrowd Newswire
20 Jul 2021, 14:59 GMT+10
The Latest Released Veterinary Pharmaceuticals market study has evaluated the future growth potential of Veterinary Pharmaceuticals market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities and restraints in Veterinary Pharmaceuticals market. The study includes market share analysis and profiles of players such as Zoetis(Pfizer), MERIAL, Merial, Lilly, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, CAHIC, Ringpu, Dahuanong, TECON, BIOK, Lukang Pharma, JINYU Group, China Animal Healthcare, Jiangx
2021-2027 Global and Regional Antiviral Drugs Industry Status and Prospects Professional Market Research Report Standard Version – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Share:
ResearchAndMarkets.com s offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market as it emerges from the COVID-19 shut down.
The global cardiovascular drugs market is expected to grow from $87.79 billion in 2020 to $92.41 billion in 2021 at a compound annual growth rate (CAGR) of 5.3%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $107.77 billion in 2025 at a CAGR of 4%.
Asia pacific antiviral drugs market size to amass USD 7.2 billion by 2027
The latest business intelligence report on ‘Asia Pacific Antiviral Drugs Market’ provides comprehensive insights about this industry sphere. It offers analysis of primary growth drivers, lucrative scenarios, limits, and challenges that will influence the market, dynamics during 2021-2027. Market Study Report, LLC.
Selbyville, Delaware, May 17, 2021 (GLOBE NEWSWIRE) According to credible sources, Asia Pacific
antiviral drugs market size is estimated to accumulate USD 7.2 billion by the year 2027, showcasing substantial growth. Exceptional increase in Covid-19 cases in China, India, and Australia, leading to rising hospitalization is the primary factor driving the market growth in APAC. Reportedly, around 25 million people in Asia were tested positive until mid-March 2021.